Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis.

Singh H, Daci K, Petersen LA, Collins C, Petersen NJ, Shethia A, El-Serag HB.

Am J Gastroenterol. 2009 Oct;104(10):2543-54. doi: 10.1038/ajg.2009.324. Epub 2009 Jun 23.

2.

Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia.

Gellad ZF, Almirall D, Provenzale D, Fisher DA.

Dig Dis Sci. 2009 Nov;54(11):2497-502. doi: 10.1007/s10620-008-0653-8. Epub 2008 Dec 18.

3.

Diagnostic yield of colonoscopy based on symptoms.

Lasson A, Kilander A, Stotzer PO.

Scand J Gastroenterol. 2008 Mar;43(3):356-62.

PMID:
18938663
4.

Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival.

Wattacheril J, Kramer JR, Richardson P, Havemann BD, Green LK, Le A, El-Serag HB.

Aliment Pharmacol Ther. 2008 Nov 1;28(9):1166-74. doi: 10.1111/j.1365-2036.2008.03826.x. Epub 2008 Aug 8.

5.

Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer.

Ramos M, Esteva M, Cabeza E, Llobera J, Ruiz A.

Eur J Cancer. 2008 Mar;44(4):510-21. doi: 10.1016/j.ejca.2008.01.011. Epub 2008 Feb 12. Review.

PMID:
18272362
6.

Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark.

Korsgaard M, Pedersen L, Sørensen HT, Laurberg S.

Colorectal Dis. 2006 Oct;8(8):688-95.

PMID:
16970580
7.

Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium.

Ayanian JZ, Chrischilles EA, Fletcher RH, Fouad MN, Harrington DP, Kahn KL, Kiefe CI, Lipscomb J, Malin JL, Potosky AL, Provenzale DT, Sandler RS, van Ryn M, Wallace RB, Weeks JC, West DW.

J Clin Oncol. 2004 Aug 1;22(15):2992-6. No abstract available. Erratum in: J Clin Oncol. 2004 Dec 15;22(24):5026.

PMID:
15284250
8.

Prognostic importance of comorbidity in a hospital-based cancer registry.

Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr.

JAMA. 2004 May 26;291(20):2441-7.

PMID:
15161894
9.

Geography and the debate over Medicare reform.

Wennberg JE, Fisher ES, Skinner JS.

Health Aff (Millwood). 2002 Jul-Dec;Suppl Web Exclusives:W96-114.

11.

Colonic neoplasia in patients with nonspecific GI symptoms.

Lieberman DA, de Garmo PL, Fleischer DE, Eisen GM, Chan BK, Helfand M.

Gastrointest Endosc. 2000 Jun;51(6):647-51.

PMID:
10840294
12.

Associations among hospital capacity, utilization, and mortality of US Medicare beneficiaries, controlling for sociodemographic factors.

Fisher ES, Wennberg JE, Stukel TA, Skinner JS, Sharp SM, Freeman JL, Gittelsohn AM.

Health Serv Res. 2000 Feb;34(6):1351-62.

13.

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM.

Lancet. 1996 Nov 30;348(9040):1472-7.

PMID:
8942775
14.

Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O.

Lancet. 1996 Nov 30;348(9040):1467-71.

PMID:
8942774
15.

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F.

N Engl J Med. 1993 May 13;328(19):1365-71. Erratum in: N Engl J Med 1993 Aug 26;329(9):672.

16.

Geographic variation in expenditures for physicians' services in the United States.

Welch WP, Miller ME, Welch HG, Fisher ES, Wennberg JE.

N Engl J Med. 1993 Mar 4;328(9):621-7.

Supplemental Content

Support Center